CONTINUED OPTIMIZATION OF USE OF SGLT-2I FOR HF: IMPROVING PRESCRIPTION REFILLS OF SGLT2I AT UT TYLER INTERNAL MEDICINE RESIDENT CLINIC
Therapeutic Area: Other: Quality Improvement - Heart Failure Background: Heart failure (HF) patients face a significantly increased risk of hospitalization and cardiovascular (CV) death. Sodium-glucose transport inhibitors (SGLT2i) have been shown to reduce the risk of hospitalizations and CV death...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |